-PTI Swinging into action a day after filing an FIR against former Karnataka Chief Minister B S Yeddyurappa in connection with illegal mining, Central Bureau of Investigation (CBI) officials on Wednesday conducted simultaneous raids at the senior BJP leader’s residences here and in some other places in the state. A joint team of CBI officials from Hyderabad and Bangalore also raided residences of Mr. Yeddyurappa’s sons B Y Raghavendra, MP, and B...
More »SEARCH RESULT
Target of intolerance -Venkitesh Ramakrishnan
Religious and social groups have trampled on the freedom of expression of artists and scholars to serve their own agendas. “FOR all the big talk about India's great tradition of cultural and religious tolerance, many forces in the social life of our country and a number of established organisations, including the so-called non-political ones, have time and again resorted to blatant suppression of freedom of expression, pointing forcefully to the...
More »World Bank gives evidence of corruption in highway projects-Dipak K Dash
The World Bank's allegations of fraud and corrupt practices in highway projects funded by the multilateral agency could just be the tip of the iceberg. The Bank's report has an annexure of "collateral" evidence showing how contractors produced fake invoices and certificates to get advance from National Highways Authority of India (NHAI). The investigation team of World Bank's Institutional Integrity Unit tracked down three companies supplying aggregates (construction material) in Nepal...
More »Moratorium on Bt Brinjal-D Bandyopadhyay
On February 9, 2010, the then Minister of Environment and Forests, Government of India, Jairam Ramesh, imposed an indefinite moratorium on the introduction of Bt Brinjal in India. It is necessary and desirable to quote the order verbatim. It reads as follows: It is my duty to adopt a cautious, precautionary based approach and impose a moratorium on the release of Bt Brinjals till such time independent scientific studies establish, to...
More »Bayer to challenge Cipla’s decision to cut price of cancer drug
-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...
More »